Difficulty: Medium
Average Score: 88%
Practice
Although the etiology of hepatoblastoma is unknown, there are many associated risk factors for development of hepatoblastoma EXCEPT
Correct answer
E
Rationale
In this question, the correct answer is E, which is not provided in the options. To provide a comprehensive educational rationale:
The correct answer should be explained as follows: Hepatoblastoma is a rare liver cancer that primarily affects young children. While the exact cause is unknown, there are several associated risk factors that increase the likelihood of developing hepatoblastoma. These risk factors can include genetic syndromes like Beckwith-Wiedemann syndrome and familial adenomatous polyposis syndrome.
Now, let's address why the other options are incorrect:
A) Beckwith-Wiedemann syndrome: This option is incorrect because Beckwith-Wiedemann syndrome is actually a risk factor for hepatoblastoma. Children with this syndrome have an increased risk of developing this type of liver cancer.
B) Familial adenomatous polyposis syndrome: Similarly, this option is incorrect because individuals with familial adenomatous polyposis syndrome are also at an increased risk of developing hepatoblastoma.
C) Prematurity: Prematurity is not a known risk factor for hepatoblastoma. While premature infants may face other health challenges, this is not typically associated with an increased risk of hepatoblastoma.
D) Low birth weight: Low birth weight is also not a known risk factor for hepatoblastoma. Although low birth weight infants may have other health concerns, it is not directly linked to the development of this type of liver cancer.
Educational context: Understanding the risk factors associated with hepatoblastoma is crucial for healthcare professionals working in pediatric oncology. By recognizing these risk factors, healthcare providers can monitor high-risk patients more closely and potentially diagnose hepatoblastoma at an earlier stage, leading to improved treatment outcomes.
The correct answer should be explained as follows: Hepatoblastoma is a rare liver cancer that primarily affects young children. While the exact cause is unknown, there are several associated risk factors that increase the likelihood of developing hepatoblastoma. These risk factors can include genetic syndromes like Beckwith-Wiedemann syndrome and familial adenomatous polyposis syndrome.
Now, let's address why the other options are incorrect:
A) Beckwith-Wiedemann syndrome: This option is incorrect because Beckwith-Wiedemann syndrome is actually a risk factor for hepatoblastoma. Children with this syndrome have an increased risk of developing this type of liver cancer.
B) Familial adenomatous polyposis syndrome: Similarly, this option is incorrect because individuals with familial adenomatous polyposis syndrome are also at an increased risk of developing hepatoblastoma.
C) Prematurity: Prematurity is not a known risk factor for hepatoblastoma. While premature infants may face other health challenges, this is not typically associated with an increased risk of hepatoblastoma.
D) Low birth weight: Low birth weight is also not a known risk factor for hepatoblastoma. Although low birth weight infants may have other health concerns, it is not directly linked to the development of this type of liver cancer.
Educational context: Understanding the risk factors associated with hepatoblastoma is crucial for healthcare professionals working in pediatric oncology. By recognizing these risk factors, healthcare providers can monitor high-risk patients more closely and potentially diagnose hepatoblastoma at an earlier stage, leading to improved treatment outcomes.